4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Crossref DOI link: https://doi.org/10.1186/s13223-017-0206-9
Published Online: 2017-07-26
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Snelder, S. M.
Weersink, E. J. M.
Braunstahl, G. J.